Učitavanje...

Patient‐Reported Outcomes From a Two‐Year Head‐to‐Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis

OBJECTIVE: To report 2‐year patient‐reported outcomes (PROs) from the head‐to‐head Abatacept versus Adalimumab Comparison in Biologic‐Naive RA Subjects with Background Methotrexate (MTX) (AMPLE) trial. METHODS: AMPLE was a phase IIIb, randomized, investigator‐blinded trial. Biologic‐naive patients w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Arthritis Care Res (Hoboken)
Glavni autori: Fleischmann, Roy, Weinblatt, Michael E., Schiff, Michael, Khanna, Dinesh, Maldonado, Michael A., Nadkarni, Anagha, Furst, Daniel E.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5094537/
https://ncbi.nlm.nih.gov/pubmed/26473625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22763
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!